Logo image of BWSN

BABCOCK & WILCOX ENTERPR - BW 8 1/8 02/28/26 (BWSN) Stock Fundamental Analysis

NYSE:BWSN - New York Stock Exchange, Inc. - US05614L3087 - Currency: USD

11.28  -2.88 (-20.34%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BWSN. BWSN was compared to 97 industry peers in the Electrical Equipment industry. BWSN has a bad profitability rating. Also its financial health evaluation is rather negative. BWSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BWSN has reported negative net income.
In the past year BWSN has reported a negative cash flow from operations.
BWSN had negative earnings in 4 of the past 5 years.
BWSN had a negative operating cash flow in each of the past 5 years.
BWSN Yearly Net Income VS EBIT VS OCF VS FCFBWSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

BWSN's Return On Assets of -10.29% is in line compared to the rest of the industry. BWSN outperforms 57.73% of its industry peers.
The Return On Invested Capital of BWSN (6.94%) is better than 78.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BWSN is significantly below the industry average of 9.66%.
The last Return On Invested Capital (6.94%) for BWSN is above the 3 year average (3.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -10.29%
ROE N/A
ROIC 6.94%
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
BWSN Yearly ROA, ROE, ROICBWSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

BWSN has a better Operating Margin (4.15%) than 70.10% of its industry peers.
BWSN's Operating Margin has improved in the last couple of years.
BWSN has a Gross Margin of 24.68%. This is comparable to the rest of the industry: BWSN outperforms 53.61% of its industry peers.
In the last couple of years the Gross Margin of BWSN has grown nicely.
Industry RankSector Rank
OM 4.15%
PM (TTM) N/A
GM 24.68%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
BWSN Yearly Profit, Operating, Gross MarginsBWSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWSN is destroying value.
Compared to 1 year ago, BWSN has more shares outstanding
The number of shares outstanding for BWSN has been increased compared to 5 years ago.
The debt/assets ratio for BWSN is higher compared to a year ago.
BWSN Yearly Shares OutstandingBWSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BWSN Yearly Total Debt VS Total AssetsBWSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -1.05, we must say that BWSN is in the distress zone and has some risk of bankruptcy.
BWSN's Altman-Z score of -1.05 is in line compared to the rest of the industry. BWSN outperforms 41.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.05
ROIC/WACC0.85
WACC8.19%
BWSN Yearly LT Debt VS Equity VS FCFBWSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

BWSN has a Current Ratio of 1.26. This is a normal value and indicates that BWSN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, BWSN is not doing good in the industry: 69.07% of the companies in the same industry are doing better.
BWSN has a Quick Ratio of 1.26. This is a bad value and indicates that BWSN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BWSN (0.98) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
BWSN Yearly Current Assets VS Current LiabilitesBWSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

BWSN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.61%.
BWSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.29%.
Measured over the past years, BWSN shows a decrease in Revenue. The Revenue has been decreasing by -3.54% on average per year.
EPS 1Y (TTM)2.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.08%
Revenue 1Y (TTM)-30.29%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-11.62%

3.2 Future

The Earnings Per Share is expected to grow by 43.43% on average over the next years. This is a very strong growth
BWSN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.60% yearly.
EPS Next Y86.66%
EPS Next 2Y43.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.47%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWSN Yearly Revenue VS EstimatesBWSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
BWSN Yearly EPS VS EstimatesBWSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BWSN. In the last year negative earnings were reported.
Also next year BWSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BWSN Price Earnings VS Forward Price EarningsBWSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BWSN is valued a bit cheaper than 68.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.33
BWSN Per share dataBWSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

BWSN's earnings are expected to grow with 43.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.43%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.75%, BWSN is a good candidate for dividend investing.
In the last 3 months the price of BWSN has falen by -51.73%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 4.65, BWSN pays a better dividend. On top of this BWSN pays more dividend than 98.97% of the companies listed in the same industry.
BWSN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 11.75%

5.2 History

BWSN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BWSN Yearly Dividends per shareBWSN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of BWSN are negative and hence is the payout ratio. BWSN will probably not be able to sustain this dividend level.
DP-24.84%
EPS Next 2Y43.43%
EPS Next 3YN/A
BWSN Yearly Income VS Free CF VS DividendBWSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

More info and screens

BABCOCK & WILCOX ENTERPR - BW 8 1/8 02/28/26

NYSE:BWSN (5/8/2025, 8:04:01 PM)

11.28

-2.88 (-20.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners75.24%
Inst Owner ChangeN/A
Ins Owners3.59%
Ins Owner ChangeN/A
Market Cap1.11B
Analysts80
Price Target165.08 (1363.48%)
Short Float %0.13%
Short Ratio5.56
Dividend
Industry RankSector Rank
Dividend Yield 11.75%
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-24.84%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-15 2025-04-15 (0.5078)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2165.17%
Min EPS beat(2)-4779.86%
Max EPS beat(2)449.52%
EPS beat(4)1
Avg EPS beat(4)-2045.34%
Min EPS beat(4)-4779.86%
Max EPS beat(4)449.52%
EPS beat(8)1
Avg EPS beat(8)-1327.75%
EPS beat(12)1
Avg EPS beat(12)-927.28%
EPS beat(16)5
Avg EPS beat(16)-646.93%
Revenue beat(2)0
Avg Revenue beat(2)-9.9%
Min Revenue beat(2)-11.29%
Max Revenue beat(2)-8.5%
Revenue beat(4)0
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-11.29%
Max Revenue beat(4)-2.5%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)5
Avg Revenue beat(12)-1%
Revenue beat(16)7
Avg Revenue beat(16)0.24%
PT rev (1m)2.9%
PT rev (3m)146.13%
EPS NQ rev (1m)-21.21%
EPS NQ rev (3m)-21.21%
EPS NY rev (1m)-250%
EPS NY rev (3m)-2700%
Revenue NQ rev (1m)-8.45%
Revenue NQ rev (3m)-8.45%
Revenue NY rev (1m)-7.38%
Revenue NY rev (3m)-9.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 40.33
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.21
OCFYN/A
SpS7.29
BVpS-2.88
TBVpS-3.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.29%
ROE N/A
ROCE 8.79%
ROIC 6.94%
ROICexc 7.46%
ROICexgc 10.99%
OM 4.15%
PM (TTM) N/A
GM 24.68%
FCFM N/A
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
ROICexc(3y)4.08%
ROICexc(5y)4.44%
ROICexgc(3y)6%
ROICexgc(5y)6.49%
ROCE(3y)4.64%
ROCE(5y)4.69%
ROICexcg growth 3Y18.44%
ROICexcg growth 5Y33.31%
ROICexc growth 3Y21.33%
ROICexc growth 5Y31.59%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
F-Score2
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 8.12
Cap/Depr 67.06%
Cap/Sales 1.56%
Interest Coverage 0.8
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z -1.05
F-Score2
WACC8.19%
ROIC/WACC0.85
Cap/Depr(3y)56.25%
Cap/Depr(5y)50.83%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.08%
EPS Next Y86.66%
EPS Next 2Y43.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.29%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-11.62%
Revenue Next Year-12.47%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.97%
EBIT growth 3Y8.96%
EBIT growth 5Y36.41%
EBIT Next Year29.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-149.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180.9%
OCF growth 3YN/A
OCF growth 5YN/A